Opportunity overview
Provision of Human Papillomavirus (HPV) vaccine (2025)
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
Merck Sharpe and Dohme (UK) Limited
Match pending…
- Contract value
- £1
- Awarded
- Not supplied
- Contract signed
- 9 Oct 2025
- Award ID
- 065762-2025-1
- Status
- active
- Identifier
- 00233687
- Location
- London, UKI, EC2M 6UR, United Kingdom
Classification
- CPV33651600 — Vaccines
Lots
- Contract for the supply of human papillomavirus vaccine to be used as part of the national immunisation programme. Deliveries will be required for a four year period from December 2025. Additional information: Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.Value not stated